Country Club Trust Company n.a. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,439 shares of the healthcare conglomerate’s stock after buying an additional 146 shares during the period. Country Club Trust Company n.a.’s holdings in UnitedHealth Group were worth $1,777,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Atom Investors LP acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $1,723,000. GWM Advisors LLC raised its position in shares of UnitedHealth Group by 8.3% in the second quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock valued at $12,510,000 after buying an additional 2,397 shares during the last quarter. Seven Springs Wealth Group LLC increased its position in UnitedHealth Group by 58.6% during the second quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock worth $1,019,000 after purchasing an additional 940 shares during the last quarter. Parametric Portfolio Associates LLC increased its position in UnitedHealth Group by 2.2% during the second quarter. Parametric Portfolio Associates LLC now owns 3,874,820 shares of the healthcare conglomerate’s stock worth $1,551,633,000 after purchasing an additional 81,995 shares during the last quarter. Finally, Welch & Forbes LLC increased its position in UnitedHealth Group by 46.2% during the second quarter. Welch & Forbes LLC now owns 4,572 shares of the healthcare conglomerate’s stock worth $1,831,000 after purchasing an additional 1,445 shares during the last quarter. 86.20% of the stock is owned by institutional investors and hedge funds.
Several equities analysts recently commented on UNH shares. Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $473.00 to $476.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research report on Friday, October 15th. Mizuho boosted their price objective on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research note on Wednesday, November 10th. Credit Suisse Group boosted their price objective on shares of UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Finally, SVB Leerink initiated coverage on shares of UnitedHealth Group in a research note on Monday, September 27th. They set an “outperform” rating and a $480.00 price objective for the company. One research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $477.35.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm had revenue of $72.34 billion for the quarter, compared to the consensus estimate of $71.24 billion. During the same period in the prior year, the firm posted $3.51 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 18.84 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be issued a dividend of $1.45 per share. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.30%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.
In related news, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction dated Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now directly owns 154,403 shares in the company, valued at approximately $64,347,450.25. The disclosure for this sale can be found here. Insiders have sold 80,000 shares of company stock worth $35,743,375 over the last three months. 0.55% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Read More: How Do You Make Money With Penny Stocks?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.